Nodal	B:C0443268
skip	O
metastasis	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	O
metastasis	O
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	B:C0560435
metastasis	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	O
metastasis	O
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	O
metastasis	B:C0596869
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	O
metastasis	O
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	O
metastasis	O
in	O
thoracic	B:C0861674
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	O
metastasis	O
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	O
metastasis	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	B:C0443268
skip	O
metastasis	O
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	O
metastasis	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	B:C0560435
metastasis	O
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	O
metastasis	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	O
metastasis	B:C0596869
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	O
metastasis	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	O
metastasis	O
is	O
a	O
prognostic	B:C1514474
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	O
metastasis	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	O
metastasis	O
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	B:C4282132
,	O
but	O
its	O
role	O
in	O
esophageal	O
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

Nodal	O
skip	O
metastasis	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
:	O
a	O
cohort	O
study	O
Nodal	O
skip	O
metastasis	O
is	O
a	O
prognostic	O
factor	I:C1514474
in	O
some	O
sites	O
of	O
malignancies	O
,	O
but	O
its	O
role	O
in	O
esophageal	B:C0014859
cancer	I:C0014859
is	O
still	O
unclear	O
.	O

The	O
present	O
study	O
aimed	O
to	O
investigate	O
occurrence	O
and	O
effect	O
of	O
nodal	B:C0443268
skip	O
metastases	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
.	O

The	O
present	O
study	O
aimed	O
to	O
investigate	O
occurrence	O
and	O
effect	O
of	O
nodal	O
skip	B:C0560435
metastases	O
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
.	O

The	O
present	O
study	O
aimed	O
to	O
investigate	O
occurrence	O
and	O
effect	O
of	O
nodal	O
skip	O
metastases	O
in	O
thoracic	B:C0861674
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
.	O

All	O
578	O
patients	O
undergoing	O
esophagectomy	B:C0085198
for	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
at	O
the	O
Center	O
for	I:C1708333
Esophageal	I:C1708333
Diseases	I:C1708333
located	O
in	O
Padova	O
between	O
January	O
1992	O
and	O
December	O
2010	O
were	O
retrospectively	O
evaluated	I:C0035363
.	O

All	O
578	O
patients	O
undergoing	O
esophagectomy	O
for	O
thoracic	B:C0861674
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
at	O
the	O
Center	O
for	I:C1708333
Esophageal	I:C1708333
Diseases	I:C1708333
located	O
in	O
Padova	O
between	O
January	O
1992	O
and	O
December	O
2010	O
were	O
retrospectively	O
evaluated	I:C0035363
.	O

All	O
578	O
patients	O
undergoing	O
esophagectomy	O
for	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
at	O
the	O
Center	B:C1708333
for	I:C1708333
Esophageal	I:C1708333
Diseases	I:C1708333
located	O
in	O
Padova	O
between	O
January	O
1992	O
and	O
December	O
2010	O
were	O
retrospectively	O
evaluated	I:C0035363
.	O

All	O
578	O
patients	O
undergoing	O
esophagectomy	O
for	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
at	O
the	O
Center	O
for	I:C1708333
Esophageal	I:C1708333
Diseases	I:C1708333
located	O
in	O
Padova	O
between	O
January	O
1992	O
and	O
December	O
2010	O
were	O
retrospectively	B:C0035363
evaluated	I:C0035363
.	O

Selection	O
criteria	O
were	O
R0	B:C0677874
resection	I:C0677874
,	O
pathological	O
M0	O
stage	I:C0445034
and	O
pathological	O
lymph	O
node	I:C0806692
involvement	I:C0806692
.	O

Selection	O
criteria	O
were	O
R0	O
resection	I:C0677874
,	O
pathological	O
M0	B:C0445034
stage	I:C0445034
and	O
pathological	O
lymph	O
node	I:C0806692
involvement	I:C0806692
.	O

Selection	O
criteria	O
were	O
R0	O
resection	I:C0677874
,	O
pathological	O
M0	O
stage	I:C0445034
and	O
pathological	O
lymph	B:C0806692
node	I:C0806692
involvement	I:C0806692
.	O

Patients	O
receiving	O
neoadjuvant	B:C0600558
therapy	I:C0600558
were	O
excluded	O
.	O

The	O
selection	O
identified	O
88	O
patients	O
with	O
lymph	B:C0806692
node	I:C0806692
involvement	I:C0806692
confirmed	O
by	O
pathological	O
evaluation	O
.	O

The	O
selection	O
identified	O
88	O
patients	O
with	O
lymph	O
node	I:C0806692
involvement	I:C0806692
confirmed	O
by	O
pathological	O
evaluation	B:C0220825
.	O

Sixteen	O
patients	O
(	O
18.2	O
%	O
)	O
had	O
nodal	B:C0443268
skip	O
metastasis	O
.	O

Sixteen	O
patients	O
(	O
18.2	O
%	O
)	O
had	O
nodal	O
skip	B:C0560435
metastasis	O
.	O

Sixteen	O
patients	O
(	O
18.2	O
%	O
)	O
had	O
nodal	O
skip	O
metastasis	B:C0596869
.	O

Adjusting	O
for	O
the	O
number	O
of	O
lymph	B:C0596869
node	I:C0596869
metastases	I:C0596869
,	O
patient	O
with	O
nodal	O
skip	O
metastasis	O
had	O
similar	O
5	O
-	O
year	O
overall	O
survival	O
(	O
14	O
%	O
vs.	O
13	O
%	O
,	O
p	O
=	O
0.93	O
)	O
and	O
5	O
-	O
year	O
disease	O
free	O
survival	O
(	O
14	O
%	O
vs.	O
9	O
%	O
,	O
p	O
=	O
0.48	O
)	O
compared	O
to	O
patients	O
with	O
both	O
peritumoral	O
and	O
distant	O
lymph	O
node	I:C0596869
metastases	I:C0596869
.	O

Adjusting	O
for	O
the	O
number	O
of	O
lymph	O
node	I:C0596869
metastases	I:C0596869
,	O
patient	O
with	O
nodal	B:C0443268
skip	O
metastasis	O
had	O
similar	O
5	O
-	O
year	O
overall	O
survival	O
(	O
14	O
%	O
vs.	O
13	O
%	O
,	O
p	O
=	O
0.93	O
)	O
and	O
5	O
-	O
year	O
disease	O
free	O
survival	O
(	O
14	O
%	O
vs.	O
9	O
%	O
,	O
p	O
=	O
0.48	O
)	O
compared	O
to	O
patients	O
with	O
both	O
peritumoral	O
and	O
distant	O
lymph	O
node	I:C0596869
metastases	I:C0596869
.	O

Adjusting	O
for	O
the	O
number	O
of	O
lymph	O
node	I:C0596869
metastases	I:C0596869
,	O
patient	O
with	O
nodal	O
skip	B:C0560435
metastasis	O
had	O
similar	O
5	O
-	O
year	O
overall	O
survival	O
(	O
14	O
%	O
vs.	O
13	O
%	O
,	O
p	O
=	O
0.93	O
)	O
and	O
5	O
-	O
year	O
disease	O
free	O
survival	O
(	O
14	O
%	O
vs.	O
9	O
%	O
,	O
p	O
=	O
0.48	O
)	O
compared	O
to	O
patients	O
with	O
both	O
peritumoral	O
and	O
distant	O
lymph	O
node	I:C0596869
metastases	I:C0596869
.	O

Adjusting	O
for	O
the	O
number	O
of	O
lymph	O
node	I:C0596869
metastases	I:C0596869
,	O
patient	O
with	O
nodal	O
skip	O
metastasis	B:C0596869
had	O
similar	O
5	O
-	O
year	O
overall	O
survival	O
(	O
14	O
%	O
vs.	O
13	O
%	O
,	O
p	O
=	O
0.93	O
)	O
and	O
5	O
-	O
year	O
disease	O
free	O
survival	O
(	O
14	O
%	O
vs.	O
9	O
%	O
,	O
p	O
=	O
0.48	O
)	O
compared	O
to	O
patients	O
with	O
both	O
peritumoral	O
and	O
distant	O
lymph	O
node	I:C0596869
metastases	I:C0596869
.	O

Adjusting	O
for	O
the	O
number	O
of	O
lymph	O
node	I:C0596869
metastases	I:C0596869
,	O
patient	O
with	O
nodal	O
skip	O
metastasis	O
had	O
similar	O
5	O
-	O
year	O
overall	O
survival	O
(	O
14	O
%	O
vs.	O
13	O
%	O
,	O
p	O
=	O
0.93	O
)	O
and	O
5	O
-	O
year	O
disease	O
free	O
survival	O
(	O
14	O
%	O
vs.	O
9	O
%	O
,	O
p	O
=	O
0.48	O
)	O
compared	O
to	O
patients	O
with	O
both	O
peritumoral	B:C3897941
and	O
distant	O
lymph	O
node	I:C0596869
metastases	I:C0596869
.	O

Adjusting	O
for	O
the	O
number	O
of	O
lymph	O
node	I:C0596869
metastases	I:C0596869
,	O
patient	O
with	O
nodal	O
skip	O
metastasis	O
had	O
similar	O
5	O
-	O
year	O
overall	O
survival	O
(	O
14	O
%	O
vs.	O
13	O
%	O
,	O
p	O
=	O
0.93	O
)	O
and	O
5	O
-	O
year	O
disease	O
free	O
survival	O
(	O
14	O
%	O
vs.	O
9	O
%	O
,	O
p	O
=	O
0.48	O
)	O
compared	O
to	O
patients	O
with	O
both	O
peritumoral	O
and	O
distant	B:C0443203
lymph	O
node	I:C0596869
metastases	I:C0596869
.	O

Adjusting	O
for	O
the	O
number	O
of	O
lymph	O
node	I:C0596869
metastases	I:C0596869
,	O
patient	O
with	O
nodal	O
skip	O
metastasis	O
had	O
similar	O
5	O
-	O
year	O
overall	O
survival	O
(	O
14	O
%	O
vs.	O
13	O
%	O
,	O
p	O
=	O
0.93	O
)	O
and	O
5	O
-	O
year	O
disease	O
free	O
survival	O
(	O
14	O
%	O
vs.	O
9	O
%	O
,	O
p	O
=	O
0.48	O
)	O
compared	O
to	O
patients	O
with	O
both	O
peritumoral	O
and	O
distant	O
lymph	B:C0596869
node	I:C0596869
metastases	I:C0596869
.	O

The	O
risk	O
difference	O
of	O
nodal	B:C0443268
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	B:C0560435
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	B:C0596869
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	B:C0596869
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	B:C0596869
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	B:C0444598
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	B:C0227188
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	B:C0441994
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	B:C0227188
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	B:C1282910
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	B:C0227188
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	B:C0441959
stage	I:C0441959
vs.	O
clinical	O
N+	O
stage	I:C1272457
.	O

The	O
risk	O
difference	O
of	O
nodal	O
skip	O
metastasis	O
was	O
:	O
-	O
24.1	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
43.1	O
%	O
to	O
-	O
5.2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
compared	O
to	O
those	O
with	O
one	O
lymph	O
node	I:C0596869
metastasis	I:C0596869
;	O
-	O
2.3	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
29.8	O
%	O
to	O
25.2	O
%	O
)	O
in	O
middle	O
thoracic	O
esophagus	I:C0227188
and	O
-	O
23.0	O
%	O
(	O
95	O
%	O
C.I.	O
-	O
47.8	O
%	O
to	O
1.8	O
%	O
)	O
in	O
lower	O
thoracic	O
esophagus	I:C0227188
compared	O
to	O
upper	O
thoracic	O
esophagus	I:C0227188
;	O
18.1	O
%	O
(	O
95	O
%	O
C.I.	O
3.2	O
%	O
to	O
33.0	O
%	O
)	O
in	O
clinical	O
N0	O
stage	I:C0441959
vs.	O
clinical	O
N+	B:C1272457
stage	I:C1272457
.	O

Nodal	B:C0443268
skip	O
metastasis	O
is	O
a	O
common	O
pattern	O
of	O
metastatic	O
lymph	I:C0806692
involvement	I:C0806692
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
.	O

Nodal	O
skip	B:C0560435
metastasis	O
is	O
a	O
common	O
pattern	O
of	O
metastatic	O
lymph	I:C0806692
involvement	I:C0806692
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
.	O

Nodal	O
skip	O
metastasis	B:C0596869
is	O
a	O
common	O
pattern	O
of	O
metastatic	O
lymph	I:C0806692
involvement	I:C0806692
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
.	O

Nodal	O
skip	O
metastasis	O
is	O
a	O
common	O
pattern	O
of	O
metastatic	B:C0806692
lymph	I:C0806692
involvement	I:C0806692
in	O
thoracic	O
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
.	O

Nodal	O
skip	O
metastasis	O
is	O
a	O
common	O
pattern	O
of	O
metastatic	O
lymph	I:C0806692
involvement	I:C0806692
in	O
thoracic	B:C0861674
esophageal	I:C0861674
squamous	I:C0861674
cell	I:C0861674
carcinoma	I:C0861674
.	O

However	O
,	O
neither	O
overall	O
survival	O
nor	O
disease	O
free	O
survival	O
are	O
associated	O
with	O
nodal	B:C0443268
skip	O
metastasis	O
occurrence	O
.	O

However	O
,	O
neither	O
overall	O
survival	O
nor	O
disease	O
free	O
survival	O
are	O
associated	O
with	O
nodal	O
skip	B:C0560435
metastasis	O
occurrence	O
.	O

However	O
,	O
neither	O
overall	O
survival	O
nor	O
disease	O
free	O
survival	O
are	O
associated	O
with	O
nodal	O
skip	O
metastasis	B:C0596869
occurrence	O
.	O

